Home
>
National Drug Code (NDC)
>
PREPOPIK
PREPOPIK - 55566-9300-2 - (sodium picosulfate, magnesium oxide, and anhydrous citric acid)
Drug Information of PREPOPIK
| Product NDC: | 55566-9300 |
| Proprietary Name: | PREPOPIK |
| Non Proprietary Name: | sodium picosulfate, magnesium oxide, and anhydrous citric acid |
| Active Ingredient(s): | 12; 3.5; 10 g/16.1g; g/16.1g; mg/16.1g & nbsp; sodium picosulfate, magnesium oxide, and anhydrous citric acid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, METERED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PREPOPIK
| Product NDC: | 55566-9300 |
| Labeler Name: | Ferring Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202535 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120716 |
Package Information of PREPOPIK
| Package NDC: | 55566-9300-2 |
| Package Description: | 2 PACKET in 1 CARTON (55566-9300-2) > 16.1 g in 1 PACKET (55566-9300-0) |
NDC Information of PREPOPIK
| NDC Code | 55566-9300-2 |
| Proprietary Name | PREPOPIK |
| Package Description | 2 PACKET in 1 CARTON (55566-9300-2) > 16.1 g in 1 PACKET (55566-9300-0) |
| Product NDC | 55566-9300 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sodium picosulfate, magnesium oxide, and anhydrous citric acid |
| Dosage Form Name | POWDER, METERED |
| Route Name | ORAL |
| Start Marketing Date | 20120716 |
| Marketing Category Name | NDA |
| Labeler Name | Ferring Pharmaceuticals Inc. |
| Substance Name | ANHYDROUS CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE |
| Strength Number | 12; 3.5; 10 |
| Strength Unit | g/16.1g; g/16.1g; mg/16.1g |
| Pharmaceutical Classes | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
